GoodRx

Meet some of the newest GoodRx'ers! We're excited to welcome more of GoodRx's recent new hires. Amanda Dempsey, Andrea Tate, MBA, Amy Davis, Nicole Galli, and Veronica Moeung.

GoodRx Helps is proud to congratulate Ruth Adeyemi, PharmD candidate, as a 2024 recipient of The Students for Healthcare Equity Scholarship. Growing up in rural Nigeria, Ruth says, “I’ve seen the difference between pharmacists in the cities in Nigeria and then comparing that to the rural areas where you have no pharmacists at all...this personal experience has been my driving force to bridge healthcare access and quality gaps among patients in rural areas.”2025 scholarship applications will be accepted starting in the spring. To learn more, visit https://lnkd.in/gXFWsF4k

Having struggled to control her weight for most of her life, Tahera was looking for a solution. After finding a medication that actually worked for her, she was denied insurance coverage. That's when she turned to GoodRx. Since using GoodRx, Tahera has been able to save thousands on her weight loss medication. This allows her to spend more time and money doing the things she loves. We're glad to help Tahera and the millions of other GoodRx users save on their prescriptions.

Our medical editor Dr. Karla Robinson recently spoke to Good Housekeeping about how GoodRx helps support women in menopause with savings on medications and trusted advice from GoodRx Health. "Menopause is just one chapter in your life story. With the right support, it can be a great one," said Dr. Robinson. Read the full article here: https://lnkd.in/e8egHsCX

Get to know the winners of the GoodRx Helps for Healthcare Equity Scholarship. In the coming months we’ll be sharing the inspiring stories of these students who are breaking barriers and championing equity in the healthcare space. Follow along to see how they're making an impact in their communities. #GoodRxHelps #Scholarship #HealthcareEquity

When it comes to managing and treating viruses like the flu, the value of real time, credible data can’t be understated. Ongoing changes in the CDC’s communication tools, along with the administration’s order to stop collaborating with the WHO, leave critical gaps in virus surveillance. Hospitals, researchers, and many other healthcare professionals rely on reporting tools, like the CDC FluView tracker, to manage resources—a practice that is even more important during our seasonal “tripledemic” when the flu, COVID-19, and RSV are spiking across the country. While the future of these national resources remains in flux, there is growing confusion around what data is currently available and where people can access it. Though I hope these issues are soon resolved so everyone in our industry can get the information they need to maintain public health, GoodRx Research is providing weekly, live updates of prescription fills for flu, COVID-19, and RSV treatments. Right now, flu cases are spiking and fills for Tamiflu are at the highest level since 2018. Because these fast-spreading viruses are so unpredictable, analyzing these medication trends helps to give healthcare administrators, doctors, nurses, and other frontline workers a real-time pulse on surges. This data is incredibly valuable for tracking which treatments Americans are taking and how treatment patterns compare to prior years or seasons. You can stay up to date on the latest fill data here: https://lnkd.in/eBqYqS68

Our free telehealth offer is still available for Angelenos in need. Talk to a healthcare professional online for $0 using promo code LA-GOODRX-CARE. See goodrx.com/care or call 737-379-1416 to get started. Read more from ABC News about how GoodRx Care can be a resource for SoCal residents who have been impacted by the wildfires and missing their critical prescription medications. https://lnkd.in/gSmDTDPj

From 2019 to 2024, the average price per insulin unit dropped by 42% to the lowest average recorded in a decade. Products such as Lantus, Novolin N, Humalog, and Humulin N have all seen meaningful reductions. See the latest data compiled by the GoodRx Research team: #insulin #diabetes #prescriptionprices

Dorothy Gemmell, GoodRx’s CCO recently authored a guest post for Drug Channels Institute, an HMP Global Company about 2025 trends, challenges, and opportunities for brands as it relates to patient access and medication affordability. She also touches on the growth in cash pay as patients increasingly become the payer, even when they have insurance. From unfilled prescriptions to compressed margins to inaccessible brand-name drugs, the prescription drug system is under intense pressure to evolve. Couple this with consumers paying more out of pocket and it’s clear that patients paying cash for prescriptions is a trend that may be here to stay. Click the link to learn more about GoodRx’s POV, and our solutions, by reading the full article at Drug Channels: https://lnkd.in/er8pnkP5

Meet some of the newest GoodRx'ers! We're excited to welcome more of GoodRx's recent new hires. Marcos Montes de Oca, Erynne Zhang, Brandon Anderson, Zach Fisic, Abbie Siegel, Nicole (Poytress) Manoogian, Somto Nnyamah, Jola Washington, MBA, and Emily Richmond, MBA, MPH